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Autism spectrum disorder (ASD) patients commonly exhibit a variety of comorbid traits
including seizures, anxiety, aggressive behavior, gastrointestinal problems, motor deficits,
abnormal sensory processing, and sleep disturbances for which the cause is unknown.
These features impact negatively on daily life and can exaggerate the effects of the
core diagnostic traits (social communication deficits and repetitive behaviors). Studying
endophenotypes relevant to both core and comorbid features of ASD in rodent models can
provide insight into biological mechanisms underlying these disorders. Here we review the
characterization of endophenotypes in a selection of environmental, genetic, and behav-
ioral rodent models of ASD. In addition to exhibiting core ASD-like behaviors, each of these
animal models display one or more endophenotypes relevant to comorbid features includ-
ing altered sensory processing, seizure susceptibility, anxiety-like behavior, and disturbed
motor functions, suggesting that these traits are indicators of altered biological pathways
in ASD. However, the study of behaviors paralleling comorbid traits in animal models of
ASD is an emerging field and further research is needed to assess altered gastrointestinal
function, aggression, and disorders of sleep onset across models. Future studies should
include investigation of these endophenotypes in order to advance our understanding of
the etiology of this complex disorder.
Keywords: autism, epilepsy, sleep, motor deficits, aggression, sensory, gastrointestinal function, anxiety
Studying endophenotypes in rodent models of Autism spec-
trum disorder (ASD) can offer insights into the heterogene-
ity and underlying biological causes of this complex disorder.
Patients with ASD demonstrate a high degree of variability in
both the severity of core diagnostic symptoms (social communi-
cation deficits alongside repetitive behaviors) and in the nature
and strength of a range of associated comorbidities. If comorbid
traits associated with ASD are integral to the disorder we expect
that many of these traits will present in animal models. How-
ever, despite the prevalence of comorbidities in patients, studies
in animal models to date have largely focused on characteriz-
ing core behavioral traits. Here we review findings from salient
rodent models of ASD identifying endophenotypes that parallel
core ASD deficits in combination with one or more comorbid
traits commonly reported in patients.
ASD: COMORBID TRAITS
Comorbid traits in ASD include seizures, heightened aggression,
and anxiety disorders as well as gastrointestinal problems, altered
sensory processing, motor deficits, and sleep disorders (Table 1).
While treatment of these issues can significantly improve quality
of life for patients and their families, the biological mechanisms
underlying these symptoms and their co-expression are generally
unknown in the context of ASD.
Current estimates for the prevalence of epilepsy in ASD patients
range between 8 and 25% (Hara, 2007; Jeste, 2011; Sansa et al.,
2011; Woolfenden et al., 2012). Recent meta-analysis data show
that epilepsy is more common in ASD patients with an intel-
lectual disability (21.5 vs. 8%; Woolfenden et al., 2012). When
epilepsy and abnormal EEG data are compared within the general
ASD population, 15% of ASD subjects have an epilepsy diagnosis
whereas a larger proportion (24.6%) shows interictal epilepti-
form EEG abnormalities during sleep (Ekinci et al., 2010). Other
reports reveal that as many as 25% of ASD patients have comorbid
epilepsy, and that 45.5% show non-seizure-related EEG abnor-
malities (Parmeggiani et al., 2010). Furthermore, one third (34%)
of patients with idiopathic ASD have treatment resistant epilepsy
(Sansa et al., 2011).
Aggressive behavior and elevated anxiety are frequently
reported in children and adolescents with ASD. Caregiver surveys
suggest that as many as 68% of ASD patients show episodes of
aggression toward them (Kanne and Mazurek, 2011). Pouw et al.
(2013) found that aggression behaviors in ASD are most likely due
to a relative impairment in the understanding of the emotions of
others. It is also estimated that 40% of ASD patients have at least
one anxiety disorder (van Steensel et al., 2011). Specific phobias,
obsessive compulsive disorder, and social anxiety disorder are most
frequently observed.
A significant proportion of patients with ASD also suffer from
gastrointestinal problems (42–90%); with constipation, chronic
diarrhea, abnormal stool patterns, and stomach cramps fre-
quently reported (Parracho et al., 2005; Valicenti-McDermott
et al., 2006; Ibrahim et al., 2009; Buie et al., 2010; Wang et al.,
2011a). Alterations in gastrointestinal function in the context
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Table 1 | Clinical comorbidities commonly associated with ASD.
Domain Comorbid symptoms
Epilepsy High prevalence of epilepsy (8–25%) and EEG abnormalities (46%) in ASD patients (Amiet et al., 2008; Parmeggiani et al.,
2010; Jeste, 2011)
High rate of treatment resistant epilepsy in idiopathic autism (34%) (Dudova et al., 2011; Sansa et al., 2011)
Heightened aggression Approximately 70% of ASD patients exhibit aggression toward caregivers (Kanne and Mazurek, 2011)
Reactive aggression correlates with impairments in emotional regulation in children with ASD but not in typically developing
children (Pouw et al., 2013)
Anxiety 40% of ASD cases associated with at least one comorbid anxiety disorder (van Steensel et al., 2011)
Gastrointestinal
disturbances
Up to 90% ASD patients have chronic GI problems, most commonly constipation, also abdominal pain, diarrhea, and
bloating (Parracho et al., 2005; Ibrahim et al., 2009; Buie et al., 2010)
Sensory Tactile: heightened sensitivity to vibration and thermal pain in palm and forearm (Blakemore et al., 2006; Cascio et al., 2008)
Auditory: atypical change detection of auditory stimuli (Gomot et al., 2006; Kwakye et al., 2011)
Visual: superior performance in detail oriented tasks, deficits in motion perception (Dakin and Frith, 2005; Latham et al.,
2013; Robertson et al., 2013)
Altered olfaction and taste in high-functioning ASD patients (Bennetto et al., 2007; Dudova et al., 2011)
Motor impairment Delays in gross and fine motor domains (Jeste, 2011)
Deficits in motor planning, coordination, and gait (Rinehart et al., 2006; Jeste, 2011)
Sleep Sleep disturbances (quality, quantity, latency to sleep) found in 40–80% of children and adolescents with ASD (Allik et al.,
2006; Malow et al., 2006; Jeste, 2011)
Sleep onset problems and night waking common in 2- to 5-year-olds with ASD (Krakowiak et al., 2008)
Comorbid traits observed in patients with ASD are heterogeneous and include enhanced seizure susceptibility, heightened aggression, anxiety, gastrointestinal (GI)
disturbances, altered sensory and motor function, and sleep disorders.
of ASD are thought to be linked to the effects of anxiety and
thereby mediated via CNS function; however investigations into
mechanisms involving the enteric nervous system have not been
reported.
By far the most common changes associated with ASD are those
related to sensory processing which are present in over 90% of
individuals diagnosed with ASD (Leekam et al., 2007). Patients
with Asperger Syndrome show significantly higher sensitivity to
high frequency tactile stimuli compared to control subjects (Cas-
cio et al., 2008). Abnormalities in tactile sensitivity, as well as
hypersensitivity to hot and cold stimuli have also been reported
in adults with ASD (Blakemore et al., 2006). Auditory process-
ing deficits related to the discrimination of temporally separated
tones (Kwakye et al., 2011) and impaired odor detection thresholds
(Bennetto et al., 2007; Dudova et al., 2011) have been documented
in patients with high-functioning autism as well as subtle impair-
ments in identifying tastes (Bennetto et al., 2007). Interestingly,
aberrant motion perception can occur alongside superior visual
processing performance in detail oriented tasks, highlighting the
potential complexity of sensory changes in ASD patients (reviewed
in Dakin and Frith, 2005; also see Latham et al., 2013; Robertson
et al., 2013).
Motor abnormalities occur in 60–80% of individuals with
ASD and include hypotonia, apraxia, and subtle gait anom-
alies (see Geschwind, 2009 for review). Abnormal fine and gross
motor function, as well as delayed motor learning, dyspraxia,
and postural abnormalities are also commonly reported in ASD
patients (reviewed in Jeste, 2011). Finally, difficulties initiating
sleep, frequent night time waking, and insomnia are frequently
reported in children with ASD (Allik et al., 2006; Malow et al.,
2006; Krakowiak et al., 2008; Jeste, 2011).
The systematic analysis of traits in animal models correspond-
ing to patient comorbidities can potentially provide insight into
the underlying biological mechanisms of ASD. Such outcomes may
lead to the design of new therapies and benefits to patients.
ANIMAL MODELS OF ASD
Over the last decade, a substantial number of rodent models of
ASD have been generated (reviewed in Silverman et al., 2010a;
Peca et al., 2011; Penagarikano et al., 2011; Wang et al., 2011b;
Schmeisser et al., 2012; Won et al., 2012) and demonstrate face
validity by replicating behavioral traits relevant to ASD. Well-
characterized social and communication assessment paradigms
and tests for the presence of repetitive behaviors exist for rodent
models of ASD (Silverman et al., 2010a). In addition, a battery
of tests is available to determine the presence of potential comor-
bidities including anxiety-like and aggressive behaviors, seizures,
disrupted motor activity, sleep dysfunction, and sensory process-
ing deficits (Crawley, 2007) as well as assays for gastrointesti-
nal motility dysfunction (Roberts et al., 2007) in these models.
Here we outline findings derived from investigations using these
tests (Table 2) and highlight areas requiring further research
(Table 3).
Animal models are discussed in three groups; (i) models with
acquired behaviors resulting from environmental insult, (ii) mod-
els expressing a human genetic mutation associated with ASD,
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Table 2 | Endophenotypes identified in rodent models relevant to comorbid features of ASD.
Domain Model Behavior
Seizure susceptibility VPA ↑ Sensitivity to PTZ (Sobrian and Nandedkar, 1986) and electroshock-induced seizures (Kim et al.,
2011)
PPA ↑ Susceptibility to kindling with repeated intracerebroventricular infusions (MacFabe et al., 2007)
Shank3B−/− Occasional handling-induced seizures (Peca et al., 2011)
CNTNAP2 Handling-induced seizures common in adults (Penagarikano et al., 2011)
FAST ↑ Sensitivity to kindling and chemoconvulsant-induced seizures (McIntyre et al., 1999; Xu et al.,
2004; Gilby et al., 2005)
EL Handling-induced seizures (Todorova et al., 1999)
BALB/c ↑ Audiogenic seizures (Morin et al., 1994; Banko et al., 1997)
C58/J ↑ Sensitivity to PTZ-induced seizures (Nutt and Lister, 1988)
Aggression Shank2−/− ↑ Aggression in home cages although no change in resident-intruder test (Schmeisser et al., 2012)
FAST ↑ (Reinhart et al., 2004)
BALB/c ↑ (Brodkin, 2007; Velez et al., 2010)
Anxiety-like behavior VPA ↑ (Mice) (Markram et al., 2008)
Shank3B−/− ↑ (Peca et al., 2011)
Shank2−/− ↑ (Schmeisser et al., 2012; Won et al., 2012)
FAST ↑ Fear-potentiated startle (Anisman et al., 2000)
BALB/c ↑ (Brodkin, 2007)
BTBR ↑ Under some conditions (McFarlane et al., 2008; Pobbe et al., 2011)
Gastro-intestinal disturbances BALB/c Altered intestinal motility compared to C57BL/6 mice in response to serotonin antagonists (Neal
et al., 2009)
Sensory VPA ↓ PPI, ↑ tactile sensitivity (Schneider and Przewlocki, 2005), ↓ olfactory (Schneider and Przewlocki,
2005; Roullet et al., 2010) and pain (Markram et al., 2008) sensitivity
PPA ↓ Sensorimotor function (increased tendency to slip/fall during beam task; Shultz et al., 2009)
NL3R451C ↓ Acoustic startle at high decibel levels (Chadman et al., 2008)
Shank3B−/− ↓ PPI (Peca et al., 2011)
CNTNAP2 ↑ Pain and olfactory sensitivity (Penagarikano et al., 2011)
FAST ↓ Acoustic startle (Anisman et al., 2000)
BTBR ↓Thermal response (Silverman et al., 2010b)
Motor NL3R451C ↑ Latency to fall from rotarod (Chadman et al., 2008)
Shank3e4–9 Mild motor impairments (Wang et al., 2011b)
CNTNAP2 Slight ↑ motor coordination (↑ latency to fall from rotarod Penagarikano et al., 2011)
EL Delays in visuomotor development (McFadyen-Leussis and Heinrichs, 2005)
Sleep VPA Abnormal circadian rhythms (Tsujino et al., 2007)
Endophenotypes relevant to enhanced seizure susceptibility, altered sensory function, and anxiety-like behavior were observed across environmental, monogenetic,
and phenotype first models. However, each model was assessed for only a subset of the endophenotypes listed and further research is required to clarify full
endophenotypic profiles. VPA, rodents administered valproate.
and (iii) naturally occurring rodent strains that demonstrate
behavioral endophenotypes relevant to ASD.
ENVIRONMENTAL MODELS
Autism spectrum disorder-like features exhibited by environmen-
tal rodent models are generally elicited in response to an overt
insult or developmental challenge, such as exposure to toxins
resulting in altered neurological development.
Valproate models
During pregnancy, maternal exposure to the first generation
antiepileptic drug valproate has been shown to significantly
increase the risk of ASD in children (Rasalam et al., 2005;
Meador et al., 2006; Bromley et al., 2008). Valproate is a short-
chain fatty acid and is thought to reduce neuronal excitability
primarily by increasing concentrations of the inhibitory neuro-
transmitter GABA and modulating voltage-gated sodium chan-
nels (Chapman et al., 1982; Rogawski and Loscher, 2004). In
both mice and rats, exposure to valproate during gestation via
intraperitoneal injection or orally with food produces deficits
in social interaction and repetitive behaviors (Schneider and
Przewlocki, 2005; Wagner et al., 2006; Roullet et al., 2010; Kim
et al., 2011). These animals also show reduced sensitivity to
pain (Markram et al., 2008) and olfactory cues (Schneider and
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Table 3 | An overview of endophenotypes assayed in rodent models of ASD.
Seizure susceptibility Aggression Anxiety Gastrointestinal Sensory Motor coordination Sleep
VPA ↑ ↑ ↓
PPA ↑ ↓ ↓
NL3R451C ↓ ↑
Shank2 ↑ ↑
Shank3 ↑ ↑ ↓ ↓
CNTNAP2 ↑ ↑ ↑
EL ↑ ↓
C58/J ↑
BALB/c ↑ ↑ ↑
BTBR ↑ ↓
FAST ↑ ↑ ↑ ↓
Increase Decrease No change Not tested Mixed/complex
Seizure susceptibility, sensory function, motor coordination, and anxiety-like behaviors are most commonly tested across models. Aggressive behavior, gastrointesti-
nal function, and sleep cycles are generally understudied. Dual colored cells: formal aggression testing in Shank2−/− mice did not yield data suggesting abnormal
aggressive behavior, however excessive aggression was observed in home cages; PPA rats had impaired sensorimotor abilities when tested using the beam task
but showed no change in swim speed in other assays. VPA, rodents administered valproate.
Przewlocki, 2005; Roullet et al., 2010), increased tactile sensitiv-
ity (Schneider and Przewlocki, 2005), and diminished acoustic
pre-pulse inhibition, a test commonly used to index abnormal-
ities in sensorimotor gating (Schneider and Przewlocki, 2005;
Markram et al., 2008; Gandal et al., 2010; Roullet et al., 2010).
Valproate-exposed adult rats show increased levels of anxiety-
like behaviors (Markram et al., 2008) and a reduced thresh-
old for electroshock (Kim et al., 2011) and pentylenetetrazole
(PTZ)-induced seizures (Sobrian and Nandedkar, 1986). These
rats also show altered circadian rhythms characterized by fre-
quent arousal during the light/sleep phase (Tsujino et al., 2007;
Tables 2 and 3).
Propionic acid model
The gut microbiota have been suggested to play a role in the
etiology of ASD (Mulle et al., 2013). Potential mechanisms con-
tributing to ASD phenotypes are unknown, however excess toxin-
producing bacteria have been identified in patients with ASD
(Parracho et al., 2005) and increased levels of short-chain fatty
acids (such as propionic acid; PPA) produced by enteric bacte-
ria have been studied in rats (MacFabe et al., 2007). In rodent
models, administration of the endogenous short-chain fatty acids
butyric acid (Thomas et al., 2010), sodium acetate (Shultz et al.,
2008, 2009), and PPA directly into the cerebral ventricles pro-
duces endophenotypes relevant to ASD (MacFabe et al., 2007,
2011; Shultz et al., 2008, 2009; Thomas et al., 2010). Acute
intracerebral ventricular infusion of PPA in rats reduces socia-
bility and learning and also produces sensorimotor impairments
(Shultz et al., 2009). This paradigm also results in reduced cog-
nitive flexibility during reversal learning (MacFabe et al., 2011).
Furthermore, repeated intraventricular PPA infusion leads to
increased susceptibility to kindling-induced seizures and stereo-
typic behavior (MacFabe et al., 2007, 2011; Shultz et al., 2009;
Tables 2 and 3).
A small number of ASD patients (5%) show mitochondr-
ial dysfunction along with altered levels of various metabolites
suggestive of altered fatty acid processing (Frye et al., 2013). Fur-
ther investigation to assess the effects of both PPA and valproate
on gastrointestinal function (i.e., following oral administration)
is needed (see Table 3), as the short-chain fatty acid receptor
(GPR43) expressed by some mucosal enteroendocrine cells may
play a role (Karaki et al., 2006). The effects of orally adminis-
tered PPA in particular would be of interest and would serve to
strengthen construct validity of this model.
GENETIC MODELS
Many gene mutations associated with ASD code for proteins
involved in the formation and maintenance of synapses (Sud-
hof, 2008; Betancur et al., 2009; Bourgeron, 2009; Chakrabarti
et al., 2009; Betancur, 2011; Geschwind, 2011). Here we review
findings from monogenic mouse models expressing mutations in
four genes modulating synaptic function; the neuroligin-3R451C
(NL3R451C) mice (Tabuchi et al., 2007; Chadman et al., 2008) two
models expressing specific mutations in the Shank3B/ProSAP2
gene [Shank3B knockout mice and Shank3Be4–9 partial knock-
out mice (Peca et al., 2011; Wang et al., 2011b)], as well as two
SHANK2 knockout models (Schmeisser et al., 2012; Won et al.,
2012) and the contactin associated protein-like 2/Neurexin IV
(CNTNAP2/NRXN4; Penagarikano et al., 2011) knockout mouse
model (Table 2). Electrophysiological studies in these mice report
altered glutamatergic and GABAergic synaptic function (Tabuchi
et al., 2007; Etherton et al., 2009, 2011; Peca et al., 2011; Wang
et al., 2011b; Schmeisser et al., 2012; Won et al., 2012). Each of
these models also expresses strong ASD behavioral endopheno-
types suggesting a role for these genes in shaping core behaviors
relevant to ASD diagnosis. However, it is not well established
whether these animal models replicate comorbid traits observed
in patients.
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Neuroligin-3R451C mice
Neuroligins are adhesion molecules which interact with a range
of post-synaptic scaffolding proteins including Shank3 and
CNTNAP2 and bind to members of the presynaptic neurexin fam-
ily across the synaptic cleft (Sudhof, 2008; Krueger et al., 2012;
Verpelli and Sala, 2012). Mutations in the neuroligin family of
post-synaptic adhesion molecules were implicated in ASD after
a spontaneous point mutation in the gene encoding NL3 was
identified in two brothers with ASD; one with comorbid epilepsy
(Jamain et al., 2003). Mice expressing the NL3R451C mutation show
a subtle reduction in pup distress calls (on post-natal day 8) and
reduced acoustic startle (Chadman et al., 2008). Under some con-
ditions and on some genetic backgrounds, NL3R451C mice also
show impaired social interaction (Tabuchi et al., 2007; Etherton
et al., 2011). Delays in meeting developmental milestones (e.g.,
slower righting reflexes), which may appear as motor deficits early
in development, have also been observed in these mice (Chadman
et al., 2008). However, adult NL3R451C mice showed better motor
coordination in the accelerating rotarod test compared with wild
type littermates (Chadman et al., 2008).
Shank3-related models
The Shank (SH3 and multiple ankyrin repeat domains) gene
family (also known as Proline-rich synapse-associated proteins;
ProSAPs) contains three members; Shank1-3 that code for post-
synaptic scaffolding proteins involved in the recruitment of several
receptors and proteins (including the neuroligins and neurexins)
to the excitatory post-synaptic membrane (Irie et al., 1997; Meyer
et al., 2004; Baron et al., 2006; Hayashi et al., 2009; Arons et al.,
2012). Rare microdeletions within the 22q13 locus (containing
Shank3) are associated with intellectual disability, speech delay,
and ASD (Nesslinger et al., 1994; Bonaglia et al., 2006; Durand
et al., 2007). Mutations in Shank2 are also associated with ASD
(Berkel et al., 2010; Kumar, 2010). Two different genetic mod-
els in which Shank3 is altered; Shank3B−/− (Peca et al., 2011)
and Shank3e4–9 (Wang et al., 2011b) in addition to two recently
reported Shank2 knockout models (Schmeisser et al., 2012; Won
et al., 2012) demonstrate core and comorbid traits relevant to ASD.
A third model in which one full length copy of Shank3 is deleted
shows core ASD endophenotypes; however the expression of sec-
ondary/comorbid features outlined here has not been investigated
in these mice (Bozdagi et al., 2010). Shank3B−/− mice lacking
the Shank3α and β isoforms show increased repetitive behavior
(self-injurious grooming) and reduced interaction with a stranger
mouse as well as occasional handling-induced seizures (Peca et al.,
2011 and reviewed in Herbert, 2011). Shank3e4–9 mice (in which
exons 4–9 are deleted) show core ASD-like deficits including social
impairments, repetitive behaviors, and altered communication
(i.e., less complex vocalization patterns), with learning deficits and
mild motor abnormalities also evident (Wang et al., 2011b). In
addition to a role as a structural protein in the central nervous sys-
tem, Shank3 is present at enteric nervous system synapses (Huett
et al., 2009). The enteric nervous system controls gastrointesti-
nal motility and mucous secretion and therefore gene mutations
leading to changes in synaptic function (including many ASD
candidate genes) may also affect gastrointestinal function (Ger-
shon and Ratcliffe, 2004). The Shank3 mouse models of ASD are
therefore excellent candidates for investigating effects of ASD-
associated gene mutations on gastrointestinal motility. Shank2
knockout mice demonstrate abnormal vocal and social behaviors,
and increased grooming behaviors. Hyperactivity (e.g., repetitive
jumping) and anxiety-like behaviors have also been reported in
these mice (Schmeisser et al., 2012; Won et al., 2012). Schmeisser
et al. (2012) detected no change in aggressive behaviors in Shank2
knockout mice using a resident-intruder assay. Despite this neg-
ative result, a high level of aggression between Shank2 knockout
males was observed in home cages (Schmeisser et al., 2012).
CNTNAP2 mice
Genetic ablation of the contactin associated protein-like 2 (CNT-
NAP2) gene, a member of the neurexin transmembrane protein
superfamily (also known as CASPR2 and Neurexin IV), results in
ASD-like deficits in social interaction and stereotypic behaviors in
mice (Penagarikano et al., 2011). In addition, CNTNAP2 knock-
out mice show hyperactivity, impaired nest building, and frequent
handling-induced seizures after 6 months of age (Penagarikano
et al., 2011). The CNTNAP2 gene has been associated with ASD
and a recessive form of epilepsy (Strauss et al., 2006). These
mice exhibit sensory endophenotypes including hyper-reactivity
to thermal sensory stimuli and superior performance in the buried
food test, an assay for olfactory function (Penagarikano et al.,
2011). CNTNAP2 knockout mice also showed slightly improved
motor coordination on the rotarod compared to wild type litter-
mates. Perhaps surprisingly, the atypical antipsychotic risperidone
(prescribed to treat aggression and irritability in some cases of
ASD) reversed nest building deficits as well as locomotor hyper-
activity in these mice (Penagarikano et al., 2011), demonstrating
predictive validity in this model (Table 2).
Behavioral analyses in transgenic mouse models of ASD con-
firm that a range of proteins regulating synaptic function are
likely to be integral to this disorder. Most studies involving genetic
models have investigated one or two endophenotypes relevant to
patient core and comorbid traits (Tables 2 and 3). However, to
better understand the relationship between these traits a focus on
assessing the more subtle secondary endophenotypes is required.
Seizure susceptibility, gastrointestinal function, sleep cycles, and
aggressive behaviors remain to be investigated in the majority
of these genetic models of ASD (Table 3). Still, the presence of
endophenotypes relevant to comorbid traits of ASD in each of
these genetic models suggests that at least some of these traits may
be associated with the core behavioral features of the disorder.
PHENOTYPE FIRST MODELS
Interplay between genomic and non-genomic influences (e.g.,
maternal effects) is almost certainly involved in the symptom
heterogeneity associated with ASD. To further understand their
relative degree of contribution, animal models in which clinically
relevant endophenotypes occur “naturally” are of great interest.
There are currently several rodent models developed via breeding
processes alone that exhibit measurable endophenotypes relevant
to the diagnostic criteria and comorbid traits associated with
ASD. These animal models include the FAST/SLOW rats and the
C58/J, BALB/c, BtBR T+ tf/J (BTBR), and epileptic-like (EL) mice
(Tables 2 and 3).
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FAST/SLOW rats and EL mice
The FAST and SLOW rat strains were derived from parent pop-
ulations of Long Evans Hooded and Wistar rats using selective
breeding processes based on relative seizure susceptibility in the
amygdala kindling model (Racine et al., 1999). This process ulti-
mately produced a seizure-prone (FAST) and seizure-resistant
(SLOW) strain. FAST rats have since proven highly seizure-prone
in both the kindling model and in chemoconvulsant (e.g., pilo-
carpine, kainate) seizure-induction models (McIntyre et al., 1999;
Xu et al., 2004; Gilby et al., 2007; Gilby and O’Brien, 2013). EL mice,
like FAST rats, were also created via selective breeding based on rel-
ative seizure susceptibility and originated from the non-epileptic
DDY mouse strain (Meidenbauer et al., 2011). EL mice typically
exhibit handling-induced seizures by postnatal day 50–60 (Todor-
ova et al., 1999). Remarkably, the breeding processes used to create
heightened seizure sensitivity in both colonies simultaneously pro-
duced robust, comorbid ASD-like traits. Both FAST rats and EL
mice exhibit significant social impairment (Reinhart et al., 2004,
2006; Gilby et al., 2007; Lim et al., 2007; Turner et al., 2007) and
repetitive behaviors (e.g., overgrooming, self-injurious scratch-
ing, and/or myoclonic jumping; Gilby, 2008; Meidenbauer et al.,
2011) alongside delays in social, physical, and visuomotor develop-
ment (McFadyen-Leussis and Heinrichs, 2005), learning deficits,
impulsivity, and hyperactivity in various testing paradigms (Anis-
man and McIntyre, 2002; McFadyen-Leussis and Heinrichs, 2005;
Azarbar et al., 2010). FAST rats are also more aggressive than their
comparison (SLOW) strain (Reinhart et al., 2004, 2006) and show
reduced acoustic startle but enhanced fear conditioning (Anisman
et al., 2000). Thus, FAST rats and EL mice offer a similar endophe-
notypic profile relevant to core and comorbid symptoms observed
in ASD.
C58/J mice
C58/J mice naturally exhibit ASD-like traits including poor socia-
bility (Moy et al., 2008; Ryan et al., 2010), relative learning deficits,
hyperactivity (Moy et al., 2008), and stereotypic behaviors (i.e.,
jumping and flipping; Ryan et al., 2010). Interestingly, C58/J mice
also demonstrate a reduced threshold for PTZ-induced seizures
(Nutt and Lister, 1988). However, in contrast to the ASD-like
developmental delays observed in FAST and EL animals, C58/J
mice meet developmental milestones earlier than their comparison
strain (C57BL/6J; Ryan et al., 2010).
BALB/c and BTBR mice
The BALB/c and BTBR mouse strains exhibit core ASD traits in
the form of impaired social interaction and repetitive behaviors
(i.e., overgrooming and/or excessive marble burying; Brodkin,
2007; Shoji and Kato, 2009; Pearson et al., 2011). BTBR mice
also demonstrate increased social anxiety-like behavior (Pobbe
et al., 2011) although anxiety responses to novel situations are
inconsistent (McFarlane et al., 2008). BTBR mice are less reactive
to thermal (hotplate) stimuli than the C57Bl/6J standard strain
(Silverman et al., 2010b), suggesting subtle sensory changes exist
in this model. In addition, several BALB/c substrains display-
ing distinct behavioral phenotypes offer particular strengths for
comorbidity investigation. BALB/cJ mice exhibit altered gastroin-
testinal function (Neal et al., 2009) and are highly aggressive (Velez
et al., 2010) while the epilepsy-prone (EP) BALB/c substrain is
susceptible to audiogenic seizures (Morin et al., 1994; Banko et al.,
1997). Notably, BTBR and BALB models have a high incidence of
corpus callosal agenesis and severely reduced hippocampal com-
missural volumes (Wahlsten et al., 2003), which may be relevant
to reports of reduced corpus callosal volumes in ASD patients
(Anderson et al., 2011).
The characterization of ASD-relevant traits in these “natural”
models is a relatively new initiative. Still, the documented com-
monalities thus far are striking; particularly the co-expression of
repetitive behaviors and impaired social interaction together with
heightened seizure sensitivity (Table 3). Finally, while we are aware
that a few studies have investigated aggression and sensory process-
ing in these rodent models, further testing using validated assays
(Silverman et al., 2010a) should be applied to fully characterize the
presence of core and comorbid features in these models.
SUMMARY
The primary aim of this review was to compare endophenotypic
clustering within a selection of animal models of ASD. Here we
focus on models expressing at least two core ASD endopheno-
types with additional endophenotypes relevant to comorbid traits
reported in ASD patients.
ENDOPHENOTYPING: A NEW APPROACH
We report that models generated via environmental insult, genetic
manipulation, and selective breeding processes demonstrate a
number of overlapping endophenotypes (Tables 2 and 3) relevant
to both clinical comorbid (Table 1) and core traits of ASD. Detailed
investigation into the more subtle endophenotypes associated with
these models is a relatively novel approach. Indeed, many clin-
ical traits highlighted here have yet to be investigated in these
models or should be re-examined using consistent methodological
approaches. Until then any ranking of the clinical relevance of the
phenotypic profiles would be premature. Interestingly however,
enhanced seizure susceptibility, altered sensory function, anxiety-
like behaviors, and changes in motor coordination were the most
frequently reported endophenotypes across models (Table 3).
Although not routinely investigated, several of the models also
showed atypical aggressive interactions (Tables 2 and 3). Despite
evidence for disturbed sleep and abnormal gastrointestinal func-
tion in a significant number of ASD patients (see Table 1), to our
knowledge, circadian rhythms and gastrointestinal function have
only been investigated in two models; valproate-exposed rats and
BALB/c mice, respectively. As discussed, gastrointestinal motility
was insensitive to serotonin antagonists in BALB/c mice in com-
parison to a control strain (Neal et al., 2009) and valproate-treated
rats showed increased arousal during sleep compared to untreated
controls (Tsujino et al., 2007; Tables 2 and 3).
OVERLAPPING TRAITS
The presence of both core and comorbid endophenotypes in
a range of animal models suggests that at least some of these
traits may be interrelated and possibly integral to the etiology
of ASD. Some endophenotypes are indeed co-expressed across
different model constructs (for example, seizure susceptibility
is consistently increased, as are anxiety-like behaviors in exam-
ples of environmental, genetic, as well as phenotype first models;
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Table 3). Both environmental models (i.e., rodents administered
the fatty acids valproate and PPA) and phenotype first models
show heightened seizure susceptibility and anxiety-like behaviors
together with sensory and motor deficits (Table 3). In contrast,
genetic models show varied changes in sensory and motor domains
(Table 3) for which the underlying mechanisms are unknown.
FUTURE DIRECTIONS: POTENTIAL MECHANISMS
UNDERLYING ASD ENDOPHENOTYPES
Animal models are an important tool with which to tease apart the
biological mechanisms underlying ASD. Given the diverse nature
of ASD, it is unlikely that a single cause is responsible for this disor-
der and more recent research suggests some degree of interaction
between the CNS and peripheral systems. Many gene mutations
identified in patients with ASD affect synaptic function (Betancur
et al., 2009; Bourgeron, 2009; Betancur, 2011). This supports an
emerging hypothesis that ASD is primarily a disorder of neuronal
communication (Grabrucker et al., 2011; Ebert and Greenberg,
2013) and we suggest that subtle changes in neural function could
underlie many of the comorbid traits described here. For example,
it is well established that gene mutations coding for ion chan-
nels that result in altered synaptic function in the CNS can cause
seizures in patients (Helbig et al., 2008; Goldberg and Coulter,
2013). It is also important to acknowledge, however, that many
neurotransmitters and receptors that regulate neuronal commu-
nication in the CNS are of functional importance in the periphery
and may thereby contribute to common comorbid traits in patient
subsets. For example, in the case of gastrointestinal issues, many
of the synaptic genes associated with ASD including the Shanks,
neurexins,and neuroligins are also expressed in the enteric nervous
system (Huett et al., 2009; Raab et al., 2010; Zhang et al., 2013),
which regulates gastrointestinal motility and secretion. It is, there-
fore, feasible that synaptic mutations may underlie gastrointestinal
symptoms in at least a subset of patients with ASD (Gershon
and Ratcliffe, 2004) in addition to altering neuronal communica-
tion in the CNS. Future research should explore potential neural
mechanisms underlying endophenotypes, in particular, those that
are currently understudied (such as gastrointestinal disorders and
altered circadian rhythms) in animal models of ASD.
In summary, rigorous endophenotyping in animal models of
ASD can assist in identifying the molecular mechanisms under-
lying these common comorbid traits. Such information may
also contribute to the identification of putative patient subsets
within this spectrum of disorders and the subsequent tailoring
of potential therapies. However, in order to achieve these goals, a
more consistent approach in the assessment and comparison of
endophenotypes is needed.
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